Tekla Capital Management’s Idexx Laboratories IDXX Stock Holding History

Tekla Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$29.4M	Hold	58,595	–	–	1.15%	21
2023 Q1	$29.3M	Sell	58,595 -9,470	-14%	-$4.53M	1.12%	23
2022 Q4	$27.8M	Buy	68,065 +13,858	+26%	+$5.38M	1.05%	30
2022 Q3	$17.7M	Buy	54,207 +1,297	+2%	+$476K	0.72%	40
2022 Q2	$18.6M	Sell	52,910 -8,307	-14%	-$3.39M	0.73%	34
2022 Q1	$33.5M	Sell	61,217 -18,446	-23%	-$9.7M	1.18%	24
2021 Q4	$52.5M	Hold	79,663	–	–	1.69%	18
2021 Q3	$49.5M	Buy	79,663 +44,849	+129%	+$30.1M	1.6%	16
2021 Q2	$22M	Hold	34,814	–	–	0.71%	38
2021 Q1	$17M	Hold	34,814	–	–	0.59%	45
2020 Q4	$17.4M	Hold	34,814	–	–	0.61%	47
2020 Q3	$13.7M	Sell	34,814 -2,200	-6%	-$813K	0.51%	47
2020 Q2	$12.2M	Sell	37,014 -3,300	-8%	-$955K	0.47%	46
2020 Q1	$9.77M	Sell	40,314 -3,300	-8%	-$861K	0.44%	44
2019 Q4	$11.4M	Sell	43,614 -6,162	-12%	-$1.62M	0.43%	51
2019 Q3	$13.5M	Sell	49,776 -11,978	-19%	-$3.33M	0.59%	42
2019 Q2	$17M	Sell	61,754 -1,900	-3%	-$468K	0.69%	35
2019 Q1	$14.2M	Buy	63,654 +12,079	+23%	+$2.49M	0.58%	41
2018 Q4	$9.59M	Sell	51,575 -50,828	-50%	-$10.4M	0.41%	49
2018 Q3	$25.6M	Sell	102,403 -27,205	-21%	-$6.6M	0.93%	27
2018 Q2	$28.2M	Sell	129,608 -23,468	-15%	-$4.84M	1.07%	24
2018 Q1	$29.3M	Buy	153,076 +20,724	+16%	+$3.82M	1.14%	23
2017 Q4	$20.7M	Hold	132,352	–	–	0.8%	30
2017 Q3	$20.6M	Hold	132,352	–	–	0.74%	32
2017 Q2	$21.4M	Hold	132,352	–	–	0.79%	31
2017 Q1	$20.5M	Hold	132,352	–	–	0.79%	28
2016 Q4	$15.5M	Hold	132,352	–	–	0.66%	32
2016 Q3	$14.9M	Hold	132,352	–	–	0.57%	41
2016 Q2	$12.3M	Hold	132,352	–	–	0.5%	51
2016 Q1	$10.4M	Hold	132,352	–	–	0.44%	58
2015 Q4	$9.65M	Hold	132,352	–	–	0.35%	61
2015 Q3	$9.83M	Hold	132,352	–	–	0.35%	65
2015 Q2	$8.49M	Buy	132,352 +19,822	+18%	+$1.37M	0.31%	68
2015 Q1	$8.69M	Hold	112,530	–	–	0.34%	67
2014 Q4	$8.34M	Hold	112,530	–	–	0.39%	58
2014 Q3	$6.63M	Hold	112,530	–	–	0.31%	68
2014 Q2	$7.51M	Hold	112,530	–	–	0.69%	41
2014 Q1	$6.83M	Hold	112,530	–	–	0.68%	39
2013 Q4	$5.99M	Hold	112,530	–	–	0.63%	36
2013 Q3	$5.61M	Hold	112,530	–	–	0.62%	40
2013 Q2	$5.05M	Buy	+112,530	New	+$4.92M	0.69%	40

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Tekla Capital Management's IDXX Position: Q2 2023 in Review

Tekla Capital Management held its Idexx Laboratories (IDXX) position steady in Q2 2023 at 58,595 shares worth $29.4M. The position accounts for 1.15% of the portfolio, ranked #21.

Tekla Capital Management first reported a position in IDXX in Q2 2013 and has held it in 41 quarters since. The position peaked at $52.5M in Q4 2021. 1,068 funds tracked by Wall St. Rank hold IDXX as of Q2 2023.

Tekla Capital Management held 58,595 shares of Idexx Laboratories worth $29.4M as of Q2 2023.
Tekla Capital Management left its Idexx Laboratories share count unchanged in Q2 2023.
Idexx Laboratories made up 1.15% of Tekla Capital Management's portfolio in Q2 2023, its #21 holding.
Tekla Capital Management first reported a position in Idexx Laboratories in Q2 2013 and has held it in 41 quarters since.
Tekla Capital Management's Idexx Laboratories position peaked at $52.5M in Q4 2021.
1,068 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2023.

Based on Tekla Capital Management's 13F filing for Q2 2023, filed 10 Aug 2023.